ADM TRONICS UNLIMITED, INC. reported fiscal 2026 revenue of $3.35M, up 4.7% from $3.2M a year earlier, and narrowed its net loss to $100.4K from a $123.1K loss in FY 2025; diluted earnings per share were essentially flat at ($0) for both years.Financial HighlightsBusiness HighlightsOriginal SEC Fil…
PHILADELPHIA, July 10, 2026 (GLOBE NEWSWIRE) -- Context Therapeutics Inc. (“Context” or the “Company”) NASDAQ:CNTX, a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced that Context has granted a non-qualified stock option awar…
ZURICH, SWITZERLAND – July 10, 2026 -- VERAXA Biotech AG NASDAQ:VRXA; “VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer. He succeeds Torsten Bürgermeister. The company is currently in the final sta…
New York, NY, July 10, 2026 (GLOBE NEWSWIRE) -- Columbus Circle Capital Corp. III NASDAQ:CCCTU (the “Company”) and Cohen & Company Inc. (NYSE American:COHN (“Cohen & Company”) today announced the closing of the Company’s initial public offering of 23,000,000 units, which included 3,000,000 units is…
LONDON, July 10, 2026 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred investment options to purchase up to an aggregate of 548,000 ordinary shares of the Company, par value $0.025…
CAMBRIDGE, Mass., July 10, 2026 (GLOBE NEWSWIRE) -- Korro Bio, Inc. (Korro) NASDAQ:KRRO a biopharmaceutical company leveraging a novel oligonucleotide promoted editing of RNA (OPERA®) platform to develop a new class of genetic medicines for rare and highly prevalent diseases, today announced the gr…
WOOSTER, Ohio, July 10, 2026 (GLOBE NEWSWIRE) -- Main Street Financial Services Corp. OTCQX:MSWV, (the “Company”), the holding company parent of Main Street Bank Corp. (the “Bank) has declared a cash dividend of $0.15 per share of the Company’s common stock for the quarter ending June 30, 2026. The…
-- Conference call to be held Monday, July 13th at 8:00 a.m. E.T. --WALTHAM, Mass., July 10, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammato…
SAN DIEGO, CA / ACCESS Newswire / July 10, 2026 / Revelation Biosciences, Inc. NASDAQ:REVB (the "Company" or "Revelation"), a clinical-stage life sciences company developing innovative solutions to treat acute and chronic disease, today announced that its Board of Directors (the "Board") has adopte…
HONG KONG, July 10, 2026 (GLOBE NEWSWIRE) -- Pitanium Limited NASDAQ:PTNM (“Pitanium” or the “Company”), a Hong Kong-based retailer focused on the sale of proprietary skincare and personal care products, today announced that it received a delisting determination letter, dated July 7, 2026, from the…
BRISBANE, Calif., July 10, 2026 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. NASDAQ:VERA today announced that, on July 6, 2026, the Compensation Committee of the Board of Directors (Compensation Committee) of Vera Therapeutics granted inducement awards consisting of non-qualified stock options to pu…
On July 10, 2026, the company received a Nasdaq Staff Determination Letter stating it is not in compliance with Listing Rule 5550(a)(2) after its bid price stayed below $1.00 for 30 consecutive business days. Due to a reverse split effected on August 12, 2025, it is not eligible for the standard 18…
Crinetics referenced directors and executive officers as participants in the solicitation related to a proposed transaction with Parent; proxy materials and related director/officer information will be filed and made available.Original SEC Filing: Crinetics Pharmaceuticals, Inc. [ CRNX ] - 8-K - Ju…
MDWerks appointed Jeffrey Scott Hopmayer as an independent director effective June 26, 2026, following a board expansion on July 9, 2026.Original SEC Filing: MDWerks, Inc. [ MDWK ] - 8-K - Jul. 10, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important informat…
InMed Pharmaceuticals entered into Amendment No. 1 to its merger agreement with Mentari Therapeutics on Jul 06 2026. The amendment clarifies the sequence of closing steps, including a pre-closing name change to Mentari Therapeutics, a redomestication to Nevada before the merger filing, and any requ…
Cyabra completed a private placement totaling approximately $6 million through securities purchase agreements with accredited investors and appointed A.G.P./Alliance Global Partners as exclusive placement agent. The offering comprised common stock, pre-funded warrants, and Series A and B warrants w…
Z Squared entered into a First Amendment to its letter of intent for the proposed acquisition of Skycore Digital. Effective June 30, 2026, the amendment extends the drop dead date to January 15, 2027, eliminates a $500,000 break-up fee, and ends exclusivity, making discussions non-exclusive. The LO…
Lee announced that Mary Junck will retire from the board of directors, effective July 31, 2026.Original SEC Filing: LEE ENTERPRISES, Inc [ LEE ] - 8-K - Jul. 10, 2026This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note thi…
IBM NYSE:IBM drew a Neutral rating from Susquehanna as strength in quantum computing, Watsonx AI and software was offset by concerns around consulting disruption and a rich valuation.Analyst James Friedman set a $303 price target and valued IBM's quantum opportunity at $65 per share. He also pointe…
Sterling announced that Mark D. Wolf, its General Counsel, Chief Compliance Officer and Corporate Secretary, has notified the company he intends to retire later this year and will assist with the transition.Original SEC Filing: STERLING INFRASTRUCTURE, INC. [ STRL ] - 8-K - Jul. 10, 2026This is an…
